Literature DB >> 12072880

Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease.

Donald Y M Leung1, H Cody Meissner, Stanford T Shulman, Wilbert H Mason, Michael A Gerber, Mary P Glode, Barry L Myones, J Gary Wheeler, Robin Ruthazer, Patrick M Schlievert.   

Abstract

OBJECTIVES: To assess the prevalence of superantigen secreting bacteria in children with acute Kawasaki disease (KD) relative to control patients. STUDY
DESIGN: Bacterial cultures were obtained in a blinded fashion from the throat, rectum, and groin of 45 patients with untreated acute KD and 37 febrile control patients from 6 centers in the United States. Cultures were processed for the presence of superantigen-producing bacteria at a central laboratory.
RESULTS: Staphylococci or streptococci that produced superantigens (TSST-1, SEB, SEC, SPEB, SPEC) were isolated from 25 of 45 patients with KD (56%) as compared with 13 of 37 (35%) control patients (P =.078). Because SEB- and SEC-producing Staphylococcus aureus have not been associated with KD and because they do not induce a Vbeta2+ T-lymphocyte response, we analyzed the difference between groups relative to superantigens TSST-1 or SPEB/SPEC production. TSST-1 secreting S aureus or SPEB/SPEC producing group A streptococci were isolated from 20 of 45 (44%) patients with KD compared with 7 of 37 (19%) control patients (P =.019).
CONCLUSIONS: The overall isolation rates of superantigen (TSST-1, SPEB, SPEC, SEB, SEC) producing bacteria between patients with KD and febrile control patients were not statistically significant. However, future studies should further examine the potential role of Vbeta2-stimulatory superantigens (TSST-1 and SPEB/SPEC) in KD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072880     DOI: 10.1067/mpd.2002.123664

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  29 in total

1.  [Kawasaki disease in children and adolescents].

Authors:  U Neudorf
Journal:  Z Rheumatol       Date:  2011-12       Impact factor: 1.372

2.  Modelling seasonal variations in the age and incidence of Kawasaki disease to explore possible infectious aetiologies.

Authors:  Virginia E Pitzer; David Burgner; Cécile Viboud; Lone Simonsen; Viggo Andreasen; Claudia A Steiner; Marc Lipsitch
Journal:  Proc Biol Sci       Date:  2012-03-07       Impact factor: 5.349

3.  Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: A case report.

Authors:  Timothy Ronan Leahy; Eyal Cohen; Upton D Allen
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

4.  Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.

Authors:  K Matsubara; T Fukaya; K Miwa; N Shibayama; H Nigami; H Harigaya; H Nozaki; T Hirata; K Baba; T Suzuki; A Ishiguro
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

5.  [Kawasaki's disease: multiple and various aspects].

Authors:  A Bourrillon
Journal:  Arch Pediatr       Date:  2008-06       Impact factor: 1.180

6.  Engineering a soluble high-affinity receptor domain that neutralizes staphylococcal enterotoxin C in rabbit models of disease.

Authors:  D M Mattis; A R Spaulding; O N Chuang-Smith; E J Sundberg; P M Schlievert; D M Kranz
Journal:  Protein Eng Des Sel       Date:  2012-11-15       Impact factor: 1.650

Review 7.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

8.  T cell activation profiles in Kawasaki syndrome.

Authors:  P A Brogan; V Shah; L A Clarke; M J Dillon; N Klein
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

9.  Proteomics study of serum exosomes in Kawasaki disease patients with coronary artery aneurysms.

Authors:  Xiao-Fei Xie; Hong-Juan Chu; Yu-Fen Xu; Liang Hua; Zhou-Ping Wang; Ping Huang; Hong-Ling Jia; Li Zhang
Journal:  Cardiol J       Date:  2018-04-03       Impact factor: 2.737

10.  Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.

Authors:  Georgia Giannouli; Chryssa Tzoumaka-Bakoula; Ioannis Kopsidas; Paraskevi Papadogeorgou; George P Chrousos; Athanasios Michos
Journal:  Pediatr Cardiol       Date:  2013-03-06       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.